Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 4-7 February 2013


Company News Release

The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC)held its seventh meeting from 4 to 7 February 2013.

For an overview of all information available following the meeting of the PRAC, please see the table below.

The Agency publishes a new page following the PRAC meeting each month. The minutes of each PRAC meeting will be published during the week following the subsequent PRAC.

View the agenda and other sources here.

Related LinksSAE Rates in Clinical Trials

Two Months and Counting on EU PV Deadline

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.